Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9976773 | 0.95 | IDO1 (0.50) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL2802287 | 0.89 | IDO1 (0.54) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL13430587 | 0.86 | IDO1 (0.44) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL9976774 | 0.84 | BCHE (0.54) | IDO1RAB9AACHEBCHEALDH1A1 | |
| SCHEMBL9976775 | 0.84 | ACHE (0.54) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL17752846 | 0.80 | ACHE (0.53) | IDO1ACHETDP1BCHEALDH1A1 | |
| SCHEMBL9976771 | 0.78 | BCHE (0.58) | IDO1RAB9AACHEBCHEALDH1A1 | |
| SCHEMBL915196 | 0.78 | IDO1 (0.54) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL515186 | 0.76 | MAPT (0.56) | IDO1RAB9ACYP1A2CYP2A6TAAR1 | |
| SCHEMBL1740610 | 0.74 | IDO1 (0.50) | IDO1RAB9ATAAR1ACHETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622507-B2 | Substituted organosulfur compounds and methods of using thereof | ACEA BIOSCIENCES INC. (US) | 2009-11-24 | — | — | US | claimed |
| EP-1742635-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | Acea Biosciences, Inc. (US) | 2007-01-17 | — | — | EP | claimed |
| WO-2005112933-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | ACEA BIOSCIENCES INC. (US) | 2005-12-01 | — | — | WO | claimed |
| US-20050261321-A1 | Substituted organosulfur compounds and methods of using thereof | ACEA Therapeutics, Inc. | 2005-11-24 | — | — | US | claimed |
| CN-119632039-B | Application of organic bistrifluoro in promoting plant growth and plant growth promoter | 天津天开瑞来有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-119632039-A | Application of organic bistrifluoro in promoting plant growth and plant growth promoter | 天津天开瑞来有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-118253343-A | Synthesis method of symmetrical trisulfide compound and high-efficiency catalyst used by same | 常州大学 | 2024-06-28 | — | — | CN | disclosed |
| EP-1742635-B1 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | ACEA BIOSCIENCES INC (US) | 2018-03-07 | — | — | EP | disclosed |
| US-8334316-B2 | Substituted organosulfur compounds and methods of using thereof | ACEA BIOSCIENCES, INC. (US) | 2012-12-18 | — | — | US | disclosed |
| US-7622507-B2 | Substituted organosulfur compounds and methods of using thereof | ACEA BIOSCIENCES INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090192146-A1 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | ACEA BIOSCIENCES, INC. (US) | 2009-07-30 | — | — | US | disclosed |
| EP-1742635-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | Acea Biosciences, Inc. (US) | 2007-01-17 | — | — | EP | disclosed |
| WO-2005112933-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | ACEA BIOSCIENCES INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050261321-A1 | Substituted organosulfur compounds and methods of using thereof | ACEA Therapeutics, Inc. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192146-A1 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | TST, CTH, CBS | IDO1 1114/4885RAB9A 4609/4885CYP1A2 3924/4885 |
| US-20050261321-A1 | Substituted organosulfur compounds and methods of using thereof | TST, CTH, CBS | IDO1 1114/4885RAB9A 4609/4885CYP1A2 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.